Fingerprint
Dive into the research topics of 'Mepolizumab for severe eosinophilic asthma (DREAM): A multicentre, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Mepolizumab for severe eosinophilic asthma (DREAM): A multicentre, double-blind, placebo-controlled trial
Timothy David Trojan, J. Andrew Bird
Research output: Contribution to journal › Comment/debate › peer-review
1
Scopus
citations